FDA Inspection 1031350 — Vetter Pharma Fertigung GmbH & Co. KG
The FDA completed an inspection of Vetter Pharma Fertigung GmbH & Co. KG on November 10, 2017 in Langenargen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 10, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Langenargen (Germany)